Evidence map›Paper›PMID 32455813›Full record

ArticleCells2020

Consequences of

Déborah Gómez-Domínguez, Carolina Epifano, Fernando de Miguel, Albert García Castaño, Borja Vilaplana-Martí, Alberto Martín, Sandra Amarilla-Quintana, Anne T Bertrand, Gisèle Bonne, Javier Ramón-Azcón and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. CRISPR-mediated targeting of theMolecular therapy. Advances · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Déborah Gómez-DomínguezInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Carolina EpifanoFundación Andrés Marcio, niños contra la laminopatía, C/Núñez de Balboa, 11, E-28001 Madrid, Spain.
Fernando de MiguelInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Albert García CastañoInstitute for Bioengineering of Catalonia (IBEC), C/Baldiri Reixac, 10-12, E-08028 Barcelona, Spain.
Borja Vilaplana-MartíInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Alberto MartínInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Sandra Amarilla-QuintanaFundación de Investigación HM Hospitales, Plaza del Conde Valle Suchil, 2, E-28015 Madrid, Spain.
Anne T BertrandSorbonne Université, INSERM UMRS 974, Center of Research in Myology, Institut de Myologie, 75013 Paris, France.
Gisèle BonneSorbonne Université, INSERM UMRS 974, Center of Research in Myology, Institut de Myologie, 75013 Paris, France.
Javier Ramón-AzcónInstitute for Bioengineering of Catalonia (IBEC), C/Baldiri Reixac, 10-12, E-08028 Barcelona, Spain.
Miguel A Rodríguez-MillaInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Ignacio Pérez de CastroInstituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2.2, E-28029 Madrid, Spain.
Instituto de Salud Carlos III · ESInserm · FRFundación Andrés Marcio · ESHM Hospitales · ESInstitució Catalana de Recerca i Estudis Avançats · ESInstitute for Bioengineering of Catalonia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laminopathies are causally associated with mutations on the Lamin A/C gene (

Indexed as

AnimalsBase SequenceCell DifferentiationCell LineCell NucleusCell Nucleus ShapeClone CellsDNA DamageExonsFemaleLamin Type AMAP Kinase Signaling SystemMembrane ProteinsMiceMicrotubule-Associated ProteinsMuscle DevelopmentLamin Type AMembrane ProteinsMicrotubule-Associated ProteinsSUN1 protein, mouseSun2 protein, mouseTelomere-Binding ProteinsCRISPRlaminopathyLMNAnuclear envelope

Identifiers

PMID32455813
PMCPMC7291140
OpenAlexW3017045547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.